Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

46.64 +2.17 (+4.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corp

< Previous 1 2 3 4 5 6 7 8 Next >
Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Twist Bioscience Corporation Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – TWST
From The Rosen Law Firm, P.A.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating F45, Twist, DLocal, and Provident and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Investors of Twist Bioscience Corporation (NASDAQ: TWST)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
NASDAQ:TWST Investor Notice: Investigation over Possible Securities Laws Violations by Twist Bioscience Corporation
San Diego, CA -- (SBWIRE) -- 12/07/2022 -- An investigation was announced for investors of Twist Bioscience Corporation (NASDAQ:TWST) shares over potential securities laws violations by Twist... 
Via SBWire
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, and Leidos and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Veru, Twist, Leidos, and DLocal and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Twist Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Twist Bioscience Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Twist Bioscience Addresses Misleading Short-Seller Report
From Twist Bioscience Corporation
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Twist Bioscience Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Earns 2022 Great Place to Work Certification
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at JSNN NanoImpacts 2022
From Twist Bioscience Corporation
Via Business Wire
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Flash Memory Summit
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.